These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15925115)

  • 1. Responsiveness to cholinesterase inhibitors in Alzheimer's disease: a possible role for the 192 Q/R polymorphism of the PON-1 gene.
    Pola R; Flex A; Ciaburri M; Rovella E; Valiani A; Reali G; Silveri MC; Bernabei R
    Neurosci Lett; 2005 Jul; 382(3):338-41. PubMed ID: 15925115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex influences on cholinesterase inhibitor treatment in elderly individuals with Alzheimer's disease.
    Haywood WM; Mukaetova-Ladinska EB
    Am J Geriatr Pharmacother; 2006 Sep; 4(3):273-86. PubMed ID: 17062329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association analysis of the paraoxonase-1 gene with Alzheimer's disease.
    Cellini E; Tedde A; Bagnoli S; Nacmias B; Piacentini S; Bessi V; Bracco L; Sorbi S
    Neurosci Lett; 2006 Nov; 408(3):199-202. PubMed ID: 16996683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms at the paraoxonase 1 L55M and Q192R loci affect the pathophysiology of Alzheimer's disease: emphasis on the cholinergic system and beta-amyloid levels.
    Leduc V; Poirier J
    Neurodegener Dis; 2008; 5(3-4):225-7. PubMed ID: 18322397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gln192Arg polymorphism in paraoxonase 1 gene is associated with Alzheimer disease in a Chinese Han ethnic population.
    He XM; Zhang ZX; Zhang JW; Zhou YT; Tang MN; Wu CB; Hong Z
    Chin Med J (Engl); 2006 Jul; 119(14):1204-9. PubMed ID: 16863614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraoxonase 1 gene polymorphisms do not influence the response to treatment in Alzheimer's disease.
    Klimkowicz-Mrowiec A; Marona M; Spisak K; Jagiella J; Wolkow P; Szczudlik A; Slowik A
    Dement Geriatr Cogn Disord; 2011; 32(1):26-31. PubMed ID: 21829028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A preliminary study of human paraoxonase and PON 1 L/M55-PON 1 Q/R 192 polymorphisms in Turkish patients with coronary artery disease.
    Kaman D; Ilhan N; Metin K; Akbulut M; Ustündağ B
    Cell Biochem Funct; 2009 Mar; 27(2):88-92. PubMed ID: 19226538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing rational use of cholinesterase inhibitors for Alzheimer's disease in Brazil: public health strategy combining guideline with peer-review of prescriptions.
    Picon PD; Camozzato AL; Lapporte EA; Picon RV; Moser Filho H; Cerveira MO; Chaves ML
    Int J Technol Assess Health Care; 2010 Apr; 26(2):205-10. PubMed ID: 20392325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effect of cholinesterase inhibitor medications on recognition memory performance in mild to moderate Alzheimer's disease: preliminary findings.
    Crowell TA; Paramadevan J; Abdullah L; Mullan M
    J Geriatr Psychiatry Neurol; 2006 Mar; 19(1):13-5. PubMed ID: 16449754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of association between Alzheimer's disease and Gln-Arg 192 Q/R polymorphism of the PON-1 gene in an Italian population.
    Pola R; Gaetani E; Flex A; Gerardino L; Aloi F; Flore R; Serricchio M; Pola P; Bernabei R
    Dement Geriatr Cogn Disord; 2003; 15(2):88-91. PubMed ID: 12566597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinesterase inhibitors and memory.
    Pepeu G; Giovannini MG
    Chem Biol Interact; 2010 Sep; 187(1-3):403-8. PubMed ID: 19941841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing treatment effects in a clinical sample of patients with probable Alzheimer's disease treated with two different cholinesterase inhibitors.
    Caffarra P; Vezzadini G; Copelli S; Dieci F; Messa G; Nonis E; Venneri A
    Acta Biomed; 2007; 78(1):16-21. PubMed ID: 17687812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between paraoxonase 1 55 Met/Leu, paraoxonase 2 148 Ala/Gly genetic polymorphisms and coronary artery disease].
    Chi DS; Ling WH; Ma J; Xia M; Hou MJ; Wang Q; Zhu HL; Tang ZH; Yu XP
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Jun; 23(3):289-93. PubMed ID: 16767666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment pattern of Alzheimer's disease with cholinesterase inhibitors (TRAIN study)].
    Gil-Néciga E; Gobartt AL;
    Rev Neurol; 2008 Apr 16-30; 46(8):461-4. PubMed ID: 18428102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between PON 1 polymorphisms, PON activity and diabetes complications.
    Hofer SE; Bennetts B; Chan AK; Holloway B; Karschimkus C; Jenkins AJ; Silink M; Donaghue KC
    J Diabetes Complications; 2006; 20(5):322-8. PubMed ID: 16949520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies.
    Tariot PN
    J Clin Psychiatry; 2006; 67 Suppl 3():15-22; quiz 23. PubMed ID: 16649847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of cognitive rehabilitation in patients with mild cognitive impairment treated with cholinesterase inhibitors.
    Rozzini L; Costardi D; Chilovi BV; Franzoni S; Trabucchi M; Padovani A
    Int J Geriatr Psychiatry; 2007 Apr; 22(4):356-60. PubMed ID: 17117398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of serum insulin-like growth factor-I levels to predict psychiatric non-response to donepezil in patients with Alzheimer's disease.
    Tei E; Yamamoto H; Watanabe T; Miyazaki A; Nakadate T; Kato N; Mimura M
    Growth Horm IGF Res; 2008 Feb; 18(1):47-54. PubMed ID: 17714966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraoxonase gene polymorphism and vitamin levels during pregnancy: Relationship with maternal oxidative stress and neonatal birthweights.
    Min J; Park H; Park B; Kim YJ; Park J; Lee H; Ha E; Park E; Hong YC
    Reprod Toxicol; 2006 Oct; 22(3):418-24. PubMed ID: 16515855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life and cholinesterase inhibitors: a qualitative study of patients with Alzheimer's disease and their carers.
    Smith B; Chur-Hansen A; Neale A; Symon J
    Australas Psychiatry; 2008 Dec; 16(6):433-7. PubMed ID: 18777227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.